Neural Stimulation for Hand Grasp in People With Tetraplegia (AGILIS)

Functional Evaluation of the Recovery of Prehension in Persons With Tetraplegia by Implanted Neural Stimulation

A selective neural stimulation as the investigators propose allows to stimulate several muscles via a single electrode. Neural stimulation requires less energy for muscle activation. In our approach, 2 electrodes will be implanted above the elbow on the median, the ulnar and the radial nerves. This considerably reduces the number of implanted elements and therefore i) the risk of infection, ii) the risk of failure, iii) the surgical risk through minimally invasive surgery.

Our main hypothesis is that multipolar neural electrical stimulation of the median and the ulnar nerve (flexion) and the radial nerve (extension) allows:

• on the one hand, a selective, individualized motor activation (muscle by muscle)
• on the other hand, a synergistic motor activation (association of several muscles) for the purpose of production of functional movements.

Study Overview

• Status: Completed
• Conditions: Tetraplegia
• Intervention / Treatment: Other: Neurostimulation

Detailed Description

Electrical stimulation of the muscles has been used for decades in rehabilitation units specializing in the treatment of spinal cord injuries. It has been shown to be effective in building muscle and preventing muscle atrophy following spinal cord injury (SCI) or stroke. It can also be used to reduce spasticity and above all to promote functionally useful motor control. It is then a Functional Electric Stimulation (FES). In the quadriplegic person marked by a severe motor deficiency of the upper limbs, FES is today the only technique allowing to restore a functional gripping movements in the case where the active muscular resources below the elbows are missing or too weak to allow tendon transfer surgery.

Like "Freehand", all the devices using FES directly stimulate the muscles (surface, intramuscular or epimysial electrodes) and therefore require a high number of internal components with a theoretical risk of infection and greater rejection. since each muscle must be activated via an electrode (up to 12 in the case of "FreeHand"). The investigators propose instead selective neural stimulation as it allows stimulating several muscles via a single electrode. Neural stimulation requires less energy for muscle activation. In our approach, three electrodes will be implanted above the elbow on the median, the ulnar and the radial nerves. This considerably reduces the number of implanted elements and therefore i) the risk of infection, ii) the risk of failure, iii) the surgical risk thanks to minimally invasive surgery. The procedure consisted of placing a multi-contact cuff electrode around the radial, ulnar or median nerves and observing the effects of electrical neural stimulation in terms of muscle selectivity, force produced and movement induced. In a previous study, the investigators already proved through acute intra operative testing (under Ethics Committee approval, #NCT03721861) that:

No failure of the electrodes or of the stimulator was noted. For all of the 8 subjects, it was possible to selectively stimulate muscle groups to obtain the opening of the thumb and fingers, or the flexion of the thumb, fingers and obtaining possibly functional grip like the forceps with opposition of the thumb or palmar grip.

A second feasibility study (Ethics committee registration #2016-A00711-50) with 17 quadriplegic patients assessed the subject's ability to use voluntary contractions of sus lesional muscles (EMG recordings in 8 subjects) or voluntary movements of shoulders (inertial recordings in 9 subjects) to control the movements of a robotic hand or the triggering of an electrical surface stimulation of the muscles of the forearm. All of the patients managed to master the proposed interface after a short familiarization period.

On the basis of the results of these two studies, the investigator wish to take an additional step in the development of a gripping assistance device for patients with spinal cord injury by proposing the implantation of three cuff electrodes with percutaneous connection on the arm of people with tetraplegia. The electrodes will be kept in place for a period of 1 month before being definitively explanted. An implanted cable will connect the electrodes to an external connector. A preliminary study based on the implantation of only 2 electrodes (on the median and the radial nerve) was conducted in 2020 in 2 patients.vNeither of the 2 participants showed general and local comorbidity. Acceptability was optimal. None of the stimulation configurations generated contradictory movements. The success rate in task execution by the electro-stimulated hand exceeded the target of 50% (54% and 51% for patient 1 and 2 respectively). The compliance rate of the control orders in both patients was > 90% using motion IMU-based detection and 100% using EMG-based detection in patient 1. These results support the relevance of neural stimulation of the tetraplegic upper limb with a more selective approach, using multi-contact epineural electrodes with 9 and 6 contact points for the median and radial nerve respectively.

• Study Type: Interventional
• Enrollment (Actual): 2
• Phase: Not Applicable

Contacts and Locations

Study Locations

• France
  • Perpignan, France, 66000
    • Rehabilitation Center Bouffard-Vercelli USSAP

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 65 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria

1. Informed consent signed
2. Patient affiliated to a social security (state medical aid excepted).
3. Neurological level ≥ C7 4.18 years old ≤ age ≤ 65 years old,

5.complete traumatic injury: defined by an A or B score on the AIS scale. (AIS A or - complete motor deficit under injury. This is an internationally agreed standard for describing spinal cord injury) 6.neurological stability (no change in muscle testing) > 6 months, 7.post-injury duration > 6 months 8.patients without active muscle resources for conventional tendon transfer surgery on the forearm and hand

Exclusion Criteria:

1. patient deprived of liberty (by judicial or administrative decision).
2. adult patient who is subject to a legal protection measure or unable to express consent
3. participation in another ongoing clinical trial
4. pregnant or breastfeeding women or women of childbearing age without effective contraception
5. spasticity and contractures in flexion or extension of the upper limbs of a destabilizing nature.
6. unstable epilepsy with a notion of a epileptic seizure that occurred within the previous 12 months.
7. unstable cardiovascular pathology (coronary heart disease, major hypertension, heart failure, etc.).
8. infectious pathology under treatment at the inclusion visit
9. wearing a pacemaker or a spinal cord stimulator implant
10. dermatological problems contraindicating the application of surface electrodes.
11. body weight >100 kg
12. psychiatric condition and/or history contraindicating participation in research
13. any contraindications to anesthesia and/or surgery
14. hypersensitivity to low molecular weight heparin (LMWH) or to any of the excipients of the specialty used
15. history of immune-mediated heparin-induced thrombocytopenia (HIT) within the last 100 days or presence of circulating antibodies
16. clinically significant active bleeding or a condition associated with a high risk of bleeding
17. electrical mapping identified as negative during the inclusion visit, i.e. with muscles revealing a rating < 4 MRC for at least one of the extensors (ECRL, ECRB, EDC, EPL) or one of the flexors (FPL, FDS, FDP).
18. bone fracture on the upper limbs

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Neurostimulation; Implantation of 3 multicontact cuff electrodes in the upper limb of patients with tetraplegia	Other: Neurostimulation; Implantation of 3 multicontact cuff electrodes in the upper limb of patients with tetraplegia and control of the stimulation by contralateral shoulder movements

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Functional outcome: Number of successful trials (task completed) out of 5 trials with 5 preselected objects.	The objective is to show that neural electrical stimulation allows the user to master the completion of each of pre-selected gripping tasks. The evaluation criteria is the number of successful trials (task completed) out of 5 trials with 5 preselected objects. For each object, a successful gripping task is a task completed in a duration <180 sec.	Baseline prior to surgery and following surgery: Day5, Day6, Day8, Day12, Day15, Day17, Day22, Day26 and Day29

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Functional outcome	Evaluation of the patient's ability to perform functional takes (gripping, moving, letting go) of 5 objects chosen by the user, by means of multi-contact neural stimulation of the median, ulnar and radial nerves. Evaluation criterion: Canadian Occupational Performance Measure (COPM)	Following surgery from Day12: Day12, Day15, Day17, Day22, Day26 and Day29
Strength	Measurements at the beginning and end of each session, in order to follow the exhaustion of the force produced over the course of the tests. The grip force is measured for 5 seconds with two gauges for each of the 2 takes three times in a row before any evaluation of the gripping tasks and 3 times in a row at the end of the 5 objects X 5 gripping tests. The average of the 3 measures is retained Evaluation criterion: Grip strength test and pinch grip test (dynamometer)	Baseline prior to surgery and following surgery: Day5, Day6, Day8, Day12, Day15, Day17, Day22, Day26 and Day29
Fatigue	To measure a person's perception of his efforts and exertion and fatigue during each trial. Evaluation criterion: Borg test	Baseline prior to surgery and following surgery: Day5, Day6, Day8, Day12, Day15, Day17, Day22, Day26 and Day29
Self perception and psychological well being	To measure a person's perception of his well being. Evaluation criterion: The 5-item World Health Organization Well-Being Index (WHO-5)	Baseline prior to surgery and following surgery: Day8, Day15, Day22, Day29
System Usability Scale	To measure the potential usability of FES and the satisfaction provided by the use of the implanted electrical stimulation Evaluation criterion: The System Usability Scale (SUS). SUS scores have a range of 0 to 100. Scores for individual items are not meaningful on their own.The higher the score, the higher the perceived usability.	Following surgery : Day8 and Day29
Local tolerance	From the skin point of view, to look for an allergic and / or infectious dermatological lesion at the implantation site. The answer provided daily will be binary yes / no.	Following surgery: daily from Day0 to Day29
Pain assessment using the Visual Analog Scale (VAS)	From an algological point of view, assessment of the emergence or worsening of pain (score above 3/10 on the Analog Pain Scale) or a mean score above 3/10.	Baseline prior to surgery and following surgery: Day5, Day6, Day8, Day12, Day15, Day17, Day22, Day26 and Day29

Collaborators and Investigators

• Sponsor: Centre Bouffard Vercelli - USSAP
• Collaborators: Institut National de Recherche en Informatique et en Automatique; NEURINNOV
• Investigators: Principal Investigator: Charles FATTAL, MD, PhD, Centre Bouffard Vercelli - USSAP

Publications and helpful links

General Publications

• Fattal C, Teissier J, Geffrier A, Fonseca L, William L, Andreu D, Guiraud D, Azevedo-Coste C. Restoring Hand Functions in People with Tetraplegia through Multi-Contact, Fascicular, and Auto-Pilot Stimulation: A Proof-of-Concept Demonstration. J Neurotrauma. 2022 May;39(9-10):627-638. doi: 10.1089/neu.2021.0381. Epub 2022 Feb 2.

Study record dates

Study Major Dates

• Study Start (Actual): October 10, 2022
• Primary Completion (Actual): November 30, 2023
• Study Completion (Actual): December 31, 2023

Study Registration Dates

• First Submitted: August 29, 2022
• First Submitted That Met QC Criteria: September 22, 2022
• First Posted (Actual): September 27, 2022

Study Record Updates

• Last Update Posted (Estimated): January 29, 2024
• Last Update Submitted That Met QC Criteria: January 26, 2024
• Last Verified: October 1, 2022

More Information

Terms related to this study

• Keywords: Tetraplegia; Neural stimulation
• Additional Relevant MeSH Terms: Nervous System Diseases; Neurologic Manifestations; Paralysis; Quadriplegia
• Other Study ID Numbers: 2022-A00205-38

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No